JP2002207034A5 - - Google Patents

Download PDF

Info

Publication number
JP2002207034A5
JP2002207034A5 JP2001002880A JP2001002880A JP2002207034A5 JP 2002207034 A5 JP2002207034 A5 JP 2002207034A5 JP 2001002880 A JP2001002880 A JP 2001002880A JP 2001002880 A JP2001002880 A JP 2001002880A JP 2002207034 A5 JP2002207034 A5 JP 2002207034A5
Authority
JP
Japan
Prior art keywords
population
cells
platelet aggregation
dimensional distribution
scattered light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001002880A
Other languages
Japanese (ja)
Other versions
JP2002207034A (en
JP4484375B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2001002880A priority Critical patent/JP4484375B2/en
Priority claimed from JP2001002880A external-priority patent/JP4484375B2/en
Publication of JP2002207034A publication Critical patent/JP2002207034A/en
Publication of JP2002207034A5 publication Critical patent/JP2002207034A5/ja
Application granted granted Critical
Publication of JP4484375B2 publication Critical patent/JP4484375B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【請求項1】 以下の工程からなる異常細胞検出方法;
(1)試料を、血液試料中の赤血球を測定の障害とならない程度に溶解し、白血球および異常細胞を測定に好適な状態にする溶血剤と混合する工程
(2)(1)で調製した試料をフローサイトメーターで測定し、少なくとも2つの散乱光を測定する工程
(3)(2)で測定した個々の細胞の散乱光信号から異なる散乱光を2軸として、2次元分布を得る工程、
(4)2次元分布から、正常な白血球を少なくとも4つに分類計数する工程
(5)2次元分布から、リンパ球系腫瘍細胞集団、血小板凝集または大型血小板の集団、または芽球集団の分布領域を設定し、リンパ球系腫瘍細胞、血小板凝集または大型血小板、または芽球を検出する工程。
1. A method for detecting abnormal cells, comprising the following steps:
(1) The sample prepared in the step (2) (1) in which the sample is dissolved with red blood cells in the blood sample to such an extent that it does not hinder the measurement, and the white blood cells and abnormal cells are mixed with a hemolytic agent in a state suitable for measurement. Measuring with a flow cytometer and measuring at least two scattered lights (3) a step of obtaining a two-dimensional distribution using two different axes of scattered light from the scattered light signals of the individual cells measured in (2),
(4) a step of classifying and counting at least four normal leukocytes from the two-dimensional distribution; (5) a distribution area of a lymphoid tumor cell population, a platelet aggregation or large platelet population, or a blast population from the two-dimensional distribution And detecting lymphocyte tumor cells , platelet aggregation or large platelets, or blasts .

「2次元分布から、リンパ球系腫瘍細胞集団、血小板凝集または大型血小板の集団、または芽球集団の分布領域を設定し、リンパ球系腫瘍細胞、血小板凝集または大型血小板、または芽球を検出する工程」とは、例えば、X軸に側方散乱光、Y軸に前方散乱光をとって、2次元分布を描くと、図1に示すように、リンパ球系腫瘍細胞は集団を形成する。この集団を適当な解析ソフトで解析することにより、リンパ球系腫瘍細胞集団の数を算出する。血小板凝集、大型血小板、芽球も同様にして、各集団の数を算出する。各集団の数にはそれぞれ閾値を設定しておき、その設定値を超えたらメッセージを表示する。
"From the two-dimensional distribution, set the distribution area of the lymphoid tumor cell population, platelet aggregation or large platelet population, or blast population to detect lymphoid tumor cells , platelet aggregation or large platelets, or blasts In the "step", for example, when a two-dimensional distribution is drawn by using side scattered light on the X axis and forward scattered light on the Y axis, the lymphoid tumor cells form a population as shown in FIG. The number of lymphocyte tumor cell populations is calculated by analyzing this population with appropriate analysis software. The number of each group is calculated in the same manner for platelet aggregation, large platelets, and blasts. A threshold value is set for the number of each group, and a message is displayed when the threshold value is exceeded.

JP2001002880A 2001-01-10 2001-01-10 Abnormal cell detection method Expired - Lifetime JP4484375B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001002880A JP4484375B2 (en) 2001-01-10 2001-01-10 Abnormal cell detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001002880A JP4484375B2 (en) 2001-01-10 2001-01-10 Abnormal cell detection method

Publications (3)

Publication Number Publication Date
JP2002207034A JP2002207034A (en) 2002-07-26
JP2002207034A5 true JP2002207034A5 (en) 2008-02-14
JP4484375B2 JP4484375B2 (en) 2010-06-16

Family

ID=18871313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001002880A Expired - Lifetime JP4484375B2 (en) 2001-01-10 2001-01-10 Abnormal cell detection method

Country Status (1)

Country Link
JP (1) JP4484375B2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743634B2 (en) 2002-08-23 2004-06-01 Coulter International Corp. Method and apparatus for differentiating blood cells using back-scatter
FR2935802B1 (en) * 2008-09-05 2012-12-28 Horiba Abx Sas METHOD AND DEVICE FOR CLASSIFYING, VISUALIZING AND EXPLORING BIOLOGICAL DATA
WO2010071114A1 (en) * 2008-12-18 2010-06-24 シスメックス株式会社 Method for detecting cancer cells in blood sample
JP5583629B2 (en) * 2011-04-28 2014-09-03 シスメックス株式会社 White blood cell classification and counting method, white blood cell classification reagent kit, and white blood cell classification reagent
EP2520926B1 (en) * 2011-05-05 2022-06-15 Sysmex Corporation Blood analyzer, blood analysis method, and computer program product
JP2012088336A (en) * 2012-01-23 2012-05-10 Sysmex Corp Method and device for discriminating myeloblast from platelet aggregation
CN107576634B (en) * 2013-07-16 2021-07-23 成都深迈瑞医疗电子技术研究院有限公司 Blood cell analyzer and cell identification method and system thereof
JP6710512B2 (en) * 2015-09-14 2020-06-17 シスメックス株式会社 Blood analysis device, blood analysis method, and computer program
CN110383037B (en) 2017-06-20 2022-07-01 深圳迈瑞生物医疗电子股份有限公司 Platelet aggregation identification method and device and cell analyzer

Similar Documents

Publication Publication Date Title
JP2004506876A5 (en)
JP3301646B2 (en) Reagent for immature cell measurement
Yonk et al. CD4+ helper T cell depression in autism
JP3328690B2 (en) Methods and materials used to determine particle counts in flow cytometers
CN101097180B (en) Analyzer and analyzing method
US20050176152A1 (en) Method of measurement of nucleated red blood cells
Kutti et al. Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis
KR890700829A (en) Multi-part classification analysis device using light scattering technology
JP2002207034A5 (en)
IL33948A (en) Control standard for use in counting blood cells
ES8609727A1 (en) Method and reagent system for four-population differential determination of leukocytes
JPH0534251A (en) Method for preparing sample for classifying and counting leucocyte
JPS6036960A (en) Method of counting cluster, leukocyte of three section therein differ
NZ587918A (en) Apparatus and methods for flow cytometry sex sorting of animal sperm
JP4850711B2 (en) Reference control for optical measurement of nucleated red blood cells in blood samples
Terstappen et al. Increased light scattering resolution facilitates multidimensional flow cytometric analysis
WO2003006956A3 (en) Cell enumeration
Bjerknes et al. Flow cytometry for the study of phagocyte functions
JP2008503711A5 (en)
CN103597349A (en) Identifying and enumerating early granulated cells (EGCs)
McCloskey et al. Immunophenotyping of T lymphocytes by three-color flow cytometry in healthy newborns, children, and adults
Firatli et al. Clinical and immunological findings in 2 siblings with Papillon‐Lefèvre syndrome
JP4484375B2 (en) Abnormal cell detection method
JP2795746B2 (en) Methods and devices for screening cells or formers for a population exhibiting a selected property
TW201403067A (en) A method for identifying and screening cytotoxic dendritic cells